The one-carbon-cycle and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in recurrent major depressive disorder; influence of antidepressant use and depressive state?

Autor: Lok, A., Mocking, R. J. T., Assies, W. J., Koeter, M. W. J., Bockting, C. L. H., De Vries, G. J., Visser, I., Derks, E. M., Kayser, M., Schene, A. H., Trauma and Grief, Leerstoel Bockting
Přispěvatelé: Trauma and Grief, Leerstoel Bockting, Adult Psychiatry, Other departments, Clinical Psychology and Experimental Psychopathology, Genetic Identification
Rok vydání: 2014
Předmět:
Male
Oncology
Folate
SYMPTOMS
Homocysteine
Stress-related disorders Donders Center for Medical Neuroscience [Radboudumc 13]
chemistry.chemical_compound
PLASMA HOMOCYSTEINE LEVELS
Methylenetetrahydrofolate Reductase
Recurrence
Mthfr c677t
education.field_of_study
biology
THERMOLABILE VARIANT
FOLATE STATUS
U.S. ADULTS
ASSOCIATION
Middle Aged
Antidepressive Agents
Pathophysiology
Vitamin B 12
Psychiatry and Mental health
Clinical Psychology
Major depressive disorder
Antidepressant
Female
HEALTH
Adult
medicine.medical_specialty
Population
METABOLISM
Folic Acid
(NADPH2)/genetics
Internal medicine
medicine
Humans
education
Methylenetetrahydrofolate Reductase (NADPH2)
Depressive Disorder
Major

Polymorphism
Genetic

Depressive disorder
business.industry
medicine.disease
Carbon
Vitamin B 6
Endocrinology
Vitamin B6
chemistry
VITAMIN-B-12
Case-Control Studies
Methylenetetrahydrofolate reductase
OLDER WOMEN
biology.protein
Vitamin b6
business
Zdroj: Journal of affective disorders, 166, 115-123. Elsevier
Journal of Affective Disorders, 166, 115-123
Journal of Affective Disorders, 166, 115-123. ELSEVIER SCIENCE BV
Journal of Affective Disorders, 166, pp. 115-123
Journal of Affective Disorders, 166, 115-123. Elsevier
Journal of Affective Disorders, 166, 115. Elsevier
ISSN: 0165-0327
DOI: 10.1016/j.jad.2014.04.048
Popis: Item does not contain fulltext BACKGROUND: An important biological factor suggested in the pathophysiology of (recurrent) Major Depressive Disorder (MDD) concerns a polymorphism in a gene encoding for the MTHFR-enzyme of the one-carbon (1-C)-metabolism. Integratively investigating key 1-C-components (folate, homocysteine, vitamin B6 and B12), including the possible effects of antidepressant medication and depressive state, could provide more insight in the possible association between the MTHFR-polymorphism and recurrent MDD. METHODS: We compared the MTHFR C677T-polymorphism together with the key 1-C-components in clinically ascertained patients with recurrent MDD (n=137) to age- and gender-matched healthy controls (n=73). RESULTS: First, patients had lower folate (t=2.25; p=.025) as compared to controls; a difference that resolved after correction for demographics (t=1.22; p=.223). Second, patients that were depressed during sampling had lower vitamin B6 (t=-2.070; p=.038) and higher homocysteine (t=2.404; p=.016) compared to those in remission. Finally, current use of antidepressants had no influence on the 1-C-components. CONCLUSIONS: Despite investigation of a specific recurrently depressed patient population, we found no clear associations with the 1-C-cycle, except for higher homocysteine and lower vitamin B6 during the depressed state. This suggests that 1-C-cycle alterations in MDD are state-associated, possibly resulting from high levels of acute (psychological) stress, and may provide a treatment target to reduce cardiovascular risk in this population. 9 p.
Databáze: OpenAIRE